The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
Taken from the ERS Congress pre-event programme, this year in review provides an overview of the most relevant advances in diagnosis and treatment of some of the most prevalent respiratory diseases, and presents the most important studies published in the last 12 months about clinical aspects of COVID-19, chronic obstructive pulmonary disease (COPD), asthma and interstitial lung disease.
You can still register for the ERS International Congress and have access to ALL sessions from the event until the end of December.
COPD: Implementing biomarkers to improve prognosis
Speaker: Miriam Barrecheguren
Early COVID-19 treatments and what it means for respiratory patients
Speaker: Mona Bafadhel
Severe asthma: Classification and treatment
Speaker: Guy Brusselle
Interstitial lung disease: Improving classification and prognosis
Speaker: Luca Richeldi
ERS International Congress 2021 delegates can access all content and session recordings at any time until the end of December 2021. If you did not take part, you can still register to access this content.Access the platform / register